A Clinical Observation on Neuropsychology and Electrophysiology in Headache Patinets With Myofascial Trigger Points

Myofascial Trigger Points Clinical Trial

Official title:

A Clinical Observation on Neuropsychology and Electrophysiology in Headache Patinets With Myofascial Trigger Points

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03082547
• Other study ID #: myofascial trigger points
• Status: Recruiting
• Phase: N/A
• First received: March 4, 2017
• Last updated: March 12, 2017
• Start date: August 1, 2016
• Est. completion date: December 1, 2017

Study information

• Verified date: March 2017
• Source: The First Affiliated Hospital with Nanjing Medical University
• Contact: Qi Wan, professor
• Phone: 13770316989
• Email: qi_wan[@]126.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

To study the clinical characteristics of headache patients with pericranial myofascial trigger points(MTrPs),and to explore the possible pathogenesis of MTrPs,investigators hope to find the possible electrical biomarkers for clinical diagnosis and treatment, and to improve the effect of headache treatment.

Description:

A series of neuropsychological test scale including Mini-mental State Examination(MMSE),Hamilton Anxiety Rating Scale(HAMA) and Hamilton Depression Rating Scale (HMAD) were evaluated among all patients.The needle pole electromyography (EMG) inspection were practiced on subjects with myofascial trigger points ,for analysing those electrophysiological characteristics.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 1, 2017
• Est. primary completion date: December 1, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Primary headache patients with pericranial myofascial trigger points.

Exclusion Criteria:

• Cranial weeks muscle infection or trauma, medical history, physical examination, laboratory and imaging studies suggest secondary headache patients except cervicalheadache.

Related Conditions & MeSH terms

• Headache
• Myofascial Trigger Points

Locations

Country	Name	City	State
China	The needle pole electromyography	Nanjing	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
The First Affiliated Hospital with Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Electromyography	The needle pole electromyography (EMG) inspection	30 minutes
Secondary	Hamilton Anxiety Rating Scale(HAMA)	Evaluating Anxiety state: Total score without anxiety symptoms less than 7 ,> 7 points might be anxious, > 14 points must be anxious, > 21 points obvious anxiety, 29 > serious anxiety	20 minutes
Secondary	Mini-mental State Examination(MMSE)	Evaluating cognitive State, MMSE boundary between normal and abnormal value related to the degree of education, literacy (not education) group of 17 points or less, primary school (education duration of 6 years or less) group of 20 or less, secondary or above (education duration of > 6 years) group of 24 points or less, the following boundary value for cognitive function defect, above normal.	20 minutes
Secondary	Hamilton Depression Rating Scale (HMAD)	Evaluating depression state:Normal score < 8 points, 8 ~ 20 points might be depression, 20 ~ 35 must have depression, > 35 severe depression.	20 minutes